Lipella Pharmaceuticals (LIPO) Revenue & Revenue Breakdown
Lipella Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$449.62M
Latest Revenue (Q)
$80.38M
Main Segment (Y)
Grant Revenues
Lipella Pharmaceuticals Revenue by Period
Lipella Pharmaceuticals Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $449.62M | 244050.07% |
2022-12-31 | $184.16K | -28.99% |
2021-12-31 | $259.35K | -73.03% |
2020-12-31 | $961.68K | 38.42% |
2019-12-31 | $694.75K | - |
Lipella Pharmaceuticals Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $80.38M | -41.08% |
2024-06-30 | $136.43M | 93422.76% |
2024-03-31 | $145.88K | 20.72% |
2023-12-31 | $120.84K | -99.88% |
2023-09-30 | $104.05M | -2.46% |
2023-06-30 | $106.68M | 90266.63% |
2023-03-31 | $118.05K | -21.83% |
2022-12-31 | $151.01K | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | -100.00% |
2022-03-31 | $33.15K | 28.08% |
2021-12-31 | $25.88K | 100.00% |
2021-09-30 | - | -100.00% |
2021-06-30 | $148.97K | 76.30% |
2021-03-31 | $84.50K | - |
Lipella Pharmaceuticals Revenue Breakdown
Lipella Pharmaceuticals Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 22 |
---|---|
Grant Revenues | $184.16K |
Latest
Quarterly Revenue by Product
Product/Service | Sep 23 | Mar 23 |
---|---|---|
Grant Revenues | $104.05K | $118.05K |
Latest
Lipella Pharmaceuticals Revenue Breakdown by Country
Quarterly Revenue by Country
Country | Mar 23 |
---|---|
Grant Revenues | $118.05K |
Latest
Lipella Pharmaceuticals Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
LIPO | Lipella Pharmaceuticals | $449.62M | $80.38M |
FENC | Fennec Pharmaceuticals | $21.64M | $6.97M |
ICCC | ImmuCell | $17.47M | $6.01B |
SNTI | Senti Biosciences | $2.56M | - |
INBX | Inhibrx Biosciences | $1.80M | - |
ANEB | Anebulo Pharmaceuticals | - | - |
ELYM | Eliem Therapeutics | - | - |
ACRV | Acrivon Therapeutics | - | - |
CELC | Celcuity | - | - |
MNPR | Monopar Therapeutics | - | - |
MACK | Merrimack Pharmaceuticals | - | - |
PTIX | Protagenic Therapeutics | - | $50.29K |
ELVN | Enliven Therapeutics | - | - |